share_log

Myriad Genetics | 8-K: Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

Myriad Genetics | 8-K: Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

万基遗传 | 8-K:Myriad Genetics公布了强劲的2024年第一季度财务业绩;收入同比增长12%;净亏损同比显著改善,调整后的息税折旧摊销前利润为正
美股SEC公告 ·  2024/05/08 04:15
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息